Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
1,835
+204
+13% +$35.3K 0.03% 185
2026
Q1
$276K Buy
1,631
+22
+1% +$4.22K 0.03% 184
2025
Q4
$303K Buy
1,609
+1
+0.1% +$188 0.04% 180
2025
Q3
$330K Buy
1,608
+166
+12% +$35.5K 0.05% 172
2025
Q2
$321K Buy
1,442
+121
+9% +$26K 0.05% 177
2025
Q1
$272K Buy
1,321
+49
+4% +$9.76K 0.05% 191
2024
Q4
$232K Hold
1,272
0.04% 211
2024
Q3
$262K Sell
1,272
-208
-14% -$40.1K 0.05% 197
2024
Q2
$259K Sell
1,480
-28
-2% -$4.78K 0.06% 194
2024
Q1
$259K Buy
1,508
+116
+8% +$17.9K 0.06% 196
2023
Q4
$210K Buy
+1,392
New +$187K 0.06% 224

Other funds holding CTAS

Oarsman Capital's CTAS Position: Q2 2026 in Review

Oarsman Capital increased its Cintas (CTAS) stake by 13% in Q2 2026, buying an estimated $35.3K and bringing the position to 1,835 shares worth $312K. The position accounts for 0.03% of the portfolio, ranked #185.

Oarsman Capital first reported a position in CTAS in Q4 2023 and has held it in 11 quarters since. The position peaked at $330K in Q3 2025. 1,422 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Oarsman Capital held 1,835 shares of Cintas worth $312K as of Q2 2026.
  • Oarsman Capital bought 204 Cintas shares in Q2 2026, an estimated $35.3K.
  • Cintas made up 0.03% of Oarsman Capital's portfolio in Q2 2026, its #185 holding.
  • Oarsman Capital first reported a position in Cintas in Q4 2023 and has held it in 11 quarters since.
  • Oarsman Capital's Cintas position peaked at $330K in Q3 2025.
  • 1,422 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.